• 57836 Citations
  • 116 Scopus h-Index
1976 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1988 2020

Filter
Article
2020
1 Citation (Scopus)
Open Access
Leukemia, Myelomonocytic, Chronic
Risk Management
Molecular Models
Mutation
decitabine
2019
5 Citations (Scopus)

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Szuber, N., Mudireddy, M., Nicolosi, M., Penna, D., Vallapureddy, R. R., Lasho, T. L., Finke, C., Begna, K., Elliott, M. A., Hook, C. C., Wolanskyj, A. P., Patnaik, M. M., Hanson, C. A., Ketterling, R. P., Sirhan, S., Pardanani, A. D., Gangat, N., Busque, L. & Tefferi, A., Jan 1 2019, In : Mayo Clinic proceedings.

Research output: Contribution to journalArticle

Polycythemia Vera
Essential Thrombocythemia
Primary Myelofibrosis
Survival
Neoplasms
7 Citations (Scopus)

Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes, and reduces bone marrow fibrosis in patients with myelofibrosis: A phase I trial

Gangat, N., Marinaccio, C., Swords, R., Watts, J. M., Gurbuxani, S., Rademaker, A., Fought, A. J., Frankfurt, O., Altman, J. K., Wen, Q. J., Farnoud, N., Famulare, C. A., Patel, A., Tapia, R., Vallapureddy, R. R., Barath, S., Graf, A., Handlogten, A., Zblewski, D., Patnaik, M. M. & 14 others, Al-Kali, A., Dinh, Y. T., Prahl, K. E., Patel, S., Nobrega, J. C., Tejera, D., Thomassen, A., Gao, J., Ji, P., Rampal, R. K., Giles, F. J., Tefferi, A., Stein, B. & Crispino, J. D., Aug 15 2019, In : Clinical Cancer Research. 25, 16, p. 4898-4906 9 p.

Research output: Contribution to journalArticle

Aurora Kinase A
Primary Myelofibrosis
Megakaryocytes
Fibrosis
Splenomegaly

Calculator-free point-of-care prognostication in myelodysplastic syndromes

Tefferi, A., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Gangat, N., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Point-of-Care Systems
Myelodysplastic Syndromes

Essential thrombocythemia

Tefferi, A. & Pardanani, A., Nov 28 2019, In : New England Journal of Medicine. 381, 22, p. 2135-2144 10 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Etiologies of Extreme Thrombocytosis: A Contemporary Series

Hsieh, R. W., Ravindran, A., Hook, C. C., Begna, K., Ashrani, A. A., Pruthi, R. K., Marshall, A. L., Hogan, W., Litzow, M. R., Hoyer, J., Oliveira, J., Vishnu, P., Call, T. G., Al-Kali, A., Patnaik, M. M., Gangat, N., Pardanani, A. D., Tefferi, A. & Go, R. S., Aug 1 2019, In : Mayo Clinic proceedings. 94, 8, p. 1542-1550 9 p.

Research output: Contribution to journalArticle

Thrombocytosis
Hematologic Neoplasms
Outpatients
Inpatients
Splenectomy

Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis

He, R., Devine, D. J., Tu, Z. J., Mai, M., Chen, D., Nguyen, P. L., Oliveira, J., Hoyer, J., Reichard, K. K., Ollila, P. L., Al-Kali, A., Tefferi, A., Begna, K., Patnaik, M. M., Alkhateeb, H. & Viswanatha, D. S., Jan 1 2019, (Accepted/In press) In : Modern Pathology.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Mutation
4'-N-benzoylstaurosporine
United States Food and Drug Administration
Computational Biology

Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model

Vallapureddy, R. R., Mudireddy, M., Penna, D., Lasho, T. L., Finke, C. M., Hanson, C. A., Ketterling, R. P., Begna, K., Gangat, N., Pardanani, A. D. & Tefferi, A., Feb 1 2019, In : Blood Cancer Journal. 9, 2, 12.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Mutation
Anemia
Incidence
Karyotype
1 Citation (Scopus)

Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013

Al-Kali, A., Zblewski, D., Foran, J. M., Patnaik, M. M., Larrabee, B. R., Gangat, N., Begna, K., Elliott, M. A., Hogan, W., Tefferi, A., Litzow, M. R. & Go, R. S., Aug 1 2019, In : Mayo Clinic proceedings. 94, 8, p. 1467-1474 8 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Databases
Neoplasms
Survival
Refractory Anemia with Excess of Blasts
5 Citations (Scopus)
Refractory Anemia
Thrombocytosis
Myelodysplastic Syndromes
Risk Management
Mutation
8 Citations (Scopus)

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

Coston, T., Pophali, P., Vallapureddy, R., Lasho, T. L., Finke, C. M., Ketterling, R. P., Carr, R., Binder, M., Mangaonkar, A. A., Gangat, N., Al-Kali, A., Litzow, M. R., Zblewski, D., Pardanani, A. D., Tefferi, A. & Patnaik, M. M., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Myelodysplastic Syndromes
decitabine
Survival
Therapeutics
2018

20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patients

Penna, D., Lasho, T. L., Finke, C. M., Vallapureddy, R. R., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Survival
Platelet Count
Leukocyte Count
Genetic Markers
10 Citations (Scopus)

A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone

Patnaik, M. M., Rangit Vallapureddy, V., Lasho, T. L., Hoversten, K. P., Finke, C. M., Ketterling, R. P., Hanson, C. A., Gangat, N., Tefferi, A. & Pardanani, A. D., Apr 2 2018, (Accepted/In press) In : Leukemia. p. 1-6 6 p.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Systemic Mastocytosis

AKT activation is a feature of CALR mutant myeloproliferative neoplasms

Fu, C., Wen, Q. J., Marinaccio, C., Ling, T., Chen, W., Bulic, M., Lasho, T., Tefferi, A., Crispino, J. D. & Xu, K., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Neoplasms
9 Citations (Scopus)
Primary Myelofibrosis
Hematopoietic Stem Cells
Karyotype
Transplants
Survival
1 Citation (Scopus)

A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status

Begna, K., Ali, W., Gangat, N., Elliott, M. A., Al-Kali, A., Litzow, M. R., Hook, C. C., Wolanskyj, A. P., Hogan, W., Patnaik, M. M., Pardanani, A. D., Zblewski, D. L., Chen, D., He, R., Viswanatha, D., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Karyotype
Acute Myeloid Leukemia

Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?

Shenoy, N., Mudireddy, M., Vallapureddy, R., Leung, N., Pagliaro, L., Witzig, T. E., Ou, F-S., Ordog, T., Cheville, J., Patnaik, M. M., Thompson, R. H., Tefferi, A. & Begna, K., Jan 1 2018, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Renal Cell Carcinoma
Epigenomics
Nephrectomy
Population

Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation

Bikhchandani, M., Johnson, R., Tuan, B. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : Acta Haematologica. p. 67-70 4 p.

Research output: Contribution to journalArticle

Eosinophilia
Phenotype
Mutation
Acute Myeloid Leukemia
Bone Marrow
9 Citations (Scopus)

Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases

Patnaik, M. M., Pierola, A. A., Vallapureddy, R., Yalniz, F. F., Kadia, T. M., Jabbour, E. J., Lasho, T., Hanson, C. A., Ketterling, R. P., Kantarjian, H. M., Tefferi, A. & Garcia-Manero, G., Apr 25 2018, (Accepted/In press) In : Leukemia. p. 1-7 7 p.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Blast Crisis
16 Citations (Scopus)

Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts

Tefferi, A., Mudireddy, M., Mannelli, F., Begna, K., Patnaik, M. M., Hanson, C. A., Ketterling, R. P., Gangat, N., Yogarajah, M., de Stefano, V., Passamonti, F., Rosti, V., Finazzi, M. C., Rambaldi, A., Bosi, A., Guglielmelli, P., Pardanani, A. D. & Vannucchi, A. M., Feb 2 2018, (Accepted/In press) In : Leukemia. p. 1-11 11 p.

Research output: Contribution to journalArticle

Blast Crisis
Stem Cells
Transplants
Survival
Neoplasms
26 Citations (Scopus)
Leukemia, Myelomonocytic, Chronic
Risk Management
Molecular Models
Mutation
decitabine
6 Citations (Scopus)

Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management

Elliott, M. A. & Tefferi, A., Apr 1 2018, In : American Journal of Hematology. 93, 4, p. 578-587 10 p.

Research output: Contribution to journalArticle

Leukemia, Neutrophilic, Chronic
Molecular Biology
Mutation
Neutrophils
Neoplasms
3 Citations (Scopus)

Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases

Shah, S., Pardanani, A. D., Elala, Y. C., Lasho, T. L., Patnaik, M. M., Reichard, K. K., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Systemic Mastocytosis
Chromosome Aberrations
Incidence
Abnormal Karyotype
Mast-Cell Leukemia

Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide

Tefferi, A., Szuber, N., Vallapureddy, R. R., Begna, K., Patnaik, M. M., Elliott, M. A., Christopher Hook, C., Wolanskyj, A. P., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Gangat, N., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Survival Rate
Primary Myelofibrosis
Survival
Busulfan

Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosis

Szuber, N., Lasho, T. L., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Calreticulin
Primary Myelofibrosis
2 Citations (Scopus)

Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels

Tefferi, A., Nicolosi, M., Penna, D., Mudireddy, M., Szuber, N., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Gangat, N. & Pardanani, A. D., Aug 14 2018, In : Blood Advances. 2, 15, p. 1980-1984 5 p.

Research output: Contribution to journalArticle

Open Access
Primary Myelofibrosis
Cachexia
Serum Albumin
Cholesterol
2 Citations (Scopus)

Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosis

Mudireddy, M., Gangat, N., Lasho, T. L., Finke, C., Hanson, C. A., Ketterling, R. P., Ashrani, A. A., Pardanani, A. D., Nagorney, D. M. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Splenectomy
16 Citations (Scopus)

Essential thrombocythemia treatment algorithm 2018

Tefferi, A., Vannucchi, A. M. & Barbui, T., Jan 1 2018, In : Blood Cancer Journal. 8, 1, 2.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Polycythemia Vera
Thrombosis
Mutation
Therapeutics

Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients

Fan, N., Lavu, S., Hanson, C. A. & Tefferi, A., Nov 19 2018, In : Blood Cancer Journal. 8, 12, 1 p.

Research output: Contribution to journalArticle

Extramedullary Hematopoiesis
Neoplasms
1 Citation (Scopus)

FGFR1 rearranged hematological neoplasms – molecularly defined and clinically heterogeneous

Patnaik, M. M., Ketterling, R. P. & Tefferi, A., Feb 1 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-3 3 p.

Research output: Contribution to journalArticle

Hematologic Neoplasms
5 Citations (Scopus)

Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience

Oliveira, J., Coon, L. M., Frederick, L. A., Hein, M., Swanson, K. C., Savedra, M. E., Porter, T. R., Patnaik, M. M., Tefferi, A., Pardanani, A. D., Grebe, S. K., Viswanatha, D. S. & Hoyer, J., Aug 1 2018, In : American Journal of Hematology. 93, 8, p. 1029-1041 13 p.

Research output: Contribution to journalArticle

Hemoglobins
Mutation
Oxygen
2,3-Diphosphoglycerate
Restless Legs Syndrome
32 Citations (Scopus)

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis

Tefferi, A., Guglielmelli, P., Nicolosi, M., Mannelli, F., Mudireddy, M., Bartalucci, N., Finke, C. M., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Begna, K., Naseema Gangat, G., Pardanani, A. D. & Vannucchi, A. M., Mar 23 2018, (Accepted/In press) In : Leukemia. p. 1-12 12 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Mutation
Karyotype
Survival
Genetic Markers
5 Citations (Scopus)

How I treat myelofibrosis after failure of JAK inhibitors

Pardanani, A. D. & Tefferi, A., Aug 2 2018, In : Blood. 132, 5, p. 492-500 9 p.

Research output: Contribution to journalArticle

Transplants
Primary Myelofibrosis
Patient treatment
Investigational Drugs
Salvaging
6 Citations (Scopus)

Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information

Tefferi, A., Gangat, N., Mudireddy, M., Lasho, T. L., Finke, C., Begna, K., Elliott, M. A., Al-Kali, A., Litzow, M. R., Hook, C. C., Wolanskyj, A. P., Hogan, W., Patnaik, M. M., Pardanani, A. D., Zblewski, D. L., He, R., Viswanatha, D., Hanson, C. A., Ketterling, R. P., Tang, J. L. & 5 others, Chou, W. C., Lin, C. C., Tsai, C. H., Tien, H. F. & Hou, H. A., Jan 1 2018, (Accepted/In press) In : Mayo Clinic Proceedings.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Taiwan
Karyotype
Mutation
Area Under Curve
9 Citations (Scopus)

Mayo alliance prognostic system for mastocytosis: Clinical and hybrid clinical-molecular models

Pardanani, A., Shah, S., Mannelli, F., Elala, Y. C., Guglielmelli, P., Lasho, T. L., Patnaik, M. M., Gangat, N., Ketterling, R. P., Reichard, K. K., Hanson, C. A., Vannucchi, A. M. & Tefferi, A., Nov 13 2018, In : Blood Advances. 2, 21, p. 2964-2972 9 p.

Research output: Contribution to journalArticle

Open Access
Systemic Mastocytosis
Mastocytosis
Molecular Models
Confidence Intervals
Mutation
3 Citations (Scopus)

Mayo CALR mutation type classification guide using alpha helix propensity

Lasho, T. L., Finke, C. M., Tischer, A., Pardanani, A. D. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Mutation
alpha-Helical Protein Conformation
87 Citations (Scopus)

MIPSS70: Mutation-enhanced international prognostic score system for transplantation-age patients with primary myelofibrosis

Guglielmelli, P., Lasho, T. L., Rotunno, G., Mudireddy, M., Mannarelli, C., Nicolosi, M., Pacilli, A., Pardanani, A. D., Rumi, E., Rosti, V., Hanson, C. A., Mannelli, F., Ketterling, R. P., Gangat, N., Rambaldi, A., Passamonti, F., Barosi, G., Barbui, T., Cazzola, M., Vannucchi, A. M. & 1 others, Tefferi, A., Feb 1 2018, In : Journal of Clinical Oncology. 36, 4, p. 310-318 9 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Transplantation
Mutation
Cytogenetics
Survival
5 Citations (Scopus)

Momelotinib therapy for myelofibrosis: A 7-year follow-up

Tefferi, A., Barraco, D., Lasho, T. L., Shah, S., Begna, K., Al-Kali, A., Hogan, W., Litzow, M. R., Hanson, C. A., Ketterling, R. P., Gangat, N. & Pardanani, A. D., Mar 1 2018, In : Blood Cancer Journal. 8, 3, 29.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Karyotype
Mutation
Survival
Peripheral Nervous System Diseases
8 Citations (Scopus)

Mutations and karyotype predict treatment response in myelodysplastic syndromes

Idossa, D., Lasho, T. L., Finke, C. M., Ketterling, R. P., Patnaik, M. M., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Karyotype
Mutation
Therapeutics
Hematinics
15 Citations (Scopus)

Mutations and prognosis in myelodysplastic syndromes: Karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model

Gangat, N., Mudireddy, M., Lasho, T. L., Finke, C. M., Nicolosi, M., Szuber, N., Patnaik, M. M., Pardanani, A. D., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Genetic Models
Myelodysplastic Syndromes
Karyotype
Mutation
Survival

Mutations and prognosis in myeloproliferative neoplasms

Tefferi, A. & Pardanani, A. D., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Mutation
Neoplasms
7 Citations (Scopus)

Myelofibrosis Treatment Algorithm 2018

Tefferi, A., Guglielmelli, P., Pardanani, A. D. & Vannucchi, A. M., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 72.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Cytogenetics
Mutation
Transplants
Therapeutics
8 Citations (Scopus)

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger

Szuber, N., Vallapureddy, R. R., Penna, D., Lasho, T. L., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Neoplasms
Essential Thrombocythemia
Polycythemia Vera
Primary Myelofibrosis
Cytogenetics
2 Citations (Scopus)

Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates

Hoversten, K., Vallapureddy, R., Lasho, T., Finke, C., Ketterling, R., Hanson, C., Gangat, N., Tefferi, A. & Patnaik, M. M., Mar 27 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
61 Citations (Scopus)

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

Barbui, T., Tefferi, A., Vannucchi, A. M., Passamonti, F., Silver, R. T., Hoffman, R., Verstovsek, S., Mesa, R., Kiladjian, J. J., Hehlmann, R., Reiter, A., Cervantes, F., Harrison, C., Mc Mullin, M. F., Hasselbalch, H. C., Koschmieder, S., Marchetti, M., Bacigalupo, A., Finazzi, G., Kroeger, N. & 3 others, Griesshammer, M., Birgegard, G. & Barosi, G., Feb 27 2018, (Accepted/In press) In : Leukemia. p. 1-13 13 p.

Research output: Contribution to journalArticle

Philadelphia Chromosome
Primary Myelofibrosis
Polycythemia Vera
Splenomegaly
Stem Cell Transplantation
14 Citations (Scopus)

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management

Tefferi, A. & Barbui, T., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Polycythemia Vera
Risk Management
Thrombosis
Mutation
16 Citations (Scopus)

Polycythemia vera treatment algorithm 2018

Tefferi, A., Vannucchi, A. M. & Barbui, T., Jan 1 2018, In : Blood Cancer Journal. 8, 1, 3.

Research output: Contribution to journalArticle

Polycythemia Vera
Survival
Pharmaceutical Preparations
Thrombosis
Busulfan

Practice-relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm

Tefferi, A., Shah, S., Lasho, T. L., Patnaik, M. M., Reichard, K. K., Hanson, C. A., Ketterling, R. P. & Pardanani, A. D., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Systemic Mastocytosis
Hematologic Neoplasms

Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia

Ogden, J., Yui, J., Ali, W., Mudireddy, M., Al-Kali, A., Patnaik, M. M., Gangat, N., Elliott, M., Hogan, W., Hook, C., Wolanskyj-Spinner, A., Pardanani, A. D., Vilarraga, H. R., Litzow, M. R., Tefferi, A. & Begna, K., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Anthracyclines
Acute Myeloid Leukemia
17 Citations (Scopus)

Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management

Tefferi, A., Dec 1 2018, In : American Journal of Hematology. 93, 12, p. 1551-1560 10 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Risk Management
Extramedullary Hematopoiesis
Mutation
Survival